Search results
...Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory...
Morningstar· 2 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met ...
What Is a T-Cell Lymphoproliferative Disorder? Inside Halsey's Diagnosis
Health.com· 6 days agoThe singer said they were first diagnosed two years ago with systemic lupus erythematosus (SLE), the...
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Pharmaceutical Technology via Yahoo Finance· 1 day agoBased on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 5 days agoA new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists ...
High-Tech With A Human Touch: How AI Can Help Caregivers Reduce Stress
Forbes· 7 days agoThere are more than 53 million unpaid family caregivers in the United States, who provide 34 billion...
Breast cancer risk assessment tool: What it can and cannot tell you
Medical News Today· 5 days agoThe Breast Cancer Risk Assessment Tool (BCRAT) can estimate a female’s risk of developing breast...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 4 days ago"While vigilance is essential with a new class of therapy, patients, physicians and regulators...
Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoAffimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript June 12, 2024 Affimed N.V. beats...
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 6 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can...
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 3 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...